Statins and the risk of gastric cancer in diabetes patients

by Lee Jeeyun, Lee Soo Hyeon, Hur Kyu Yeon, Woo Sook Young, Kim Sun Woo, Kang Won Ki
Published 2012-12-01

Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy

by Lim Do, Seo Sung, Ahn Geung, Choi Yoon-La, Jun Hyun, Yi Seong, Lee Jeeyun, Kim Hyo, Ahn Yong, Park Joon, Kim Sung
Published 2009-06-01

A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer

by Park Joon, Park Se, Lee Jeeyun, Uhm Ji, Park Min, Chang Myung, Kim Kyoung, Jun Hyun, Kim Hyo, Yi Seong, Lim Do, Ji Sang, Park Young, Lim Ho, Kang Won
Published 2009-04-01

Metastatic lymph node in gastric cancer; Is it a real distant metastasis?

by Noh Jae, Sohn Tae, An Ji, Yi Seong, Park Min, Ji Sang, Lim Ho, Park Se, Lee Jeeyun, Park Young, Lim Do, Kim Hyeong, Bae Jae, Kim Sung, Park Cheol, Kang Won
Published 2010-01-01

Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study

by Kim Jung Han, Lee Soon Il, Lim Do Hyoung, Park Keon Woo, Oh Sung Yong, Jun Hyun Jung, Kim Eun Kyoung, Kim Hyo Song, Kim Kyoung Mee, Lee Dae Ho, Lee Jeeyun
Published 2010-04-01

Unique perception of clinical trials by Korean cancer patients

by Lee Su Jin, Park Lee Chun, Lee Jeeyun, Kim Seonwoo, Choi Moon Ki, Hong Jung Yong, Park Sylvia, Maeng Chi Hoon, Chang Wonjin, Kim Young Saing, Park Se Hoon, Park Joon Oh, Lim Ho Yeong, Kang Won Ki, Park Young Suk
Published 2012-12-01

Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition

by Sundar, Raghav, Huang, Kie-Kyon, Kumar, Vikrant, Ramnarayanan, Kalpana, Demircioglu, Deniz, Her, Zhisheng, Ong, Xuewen, Isa, Zul Fazreen Bin Adam, Xing, Manjie, Tan, Angie Lay-Keng, Tai, David Wai Meng, Choo, Su Pin, Zhai, Weiwei, Lim, Jia Qi, Das Thakur, Meghna, Molinero, Luciana, Cha, Edward, Fasso, Marcella, Niger, Monica, Pietrantonio, Filippo, Lee, Jeeyun, Jeyasekharan, Anand D, Qamra, Aditi, Patnala, Radhika, Fabritius, Arne, De Simone, Mark, Yeong, Joe, Ng, Cedric Chuan Young, Rha, Sun Young, Narita, Yukiya, Muro, Kei, Guo, Yu Amanda, Skanderup, Anders Jacobsen, So, Jimmy Bok Yan, Yong, Wei Peng, Chen, Qingfeng, Goke, Jonathan, Tan, Patrick
Published 2022

High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma

by Lee, Jeeyun, van Hummelen, Paul, Go, Christina, Jang, Jiryeon, Park, Joon Oh, Kim, Kyoung-Mee, Palescandolo, Emanuele, Park, Ha Young, Kang, So Young, Kang, Won Ki, MacConaill, Laura Eleanor
Published 2013

Clovette : predicting preferences for flowers

by Lee, Jeeyun Jennifer
Published 2016

Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study

by Kim, Hyo Song, Kim, Eun Kyoung, Jun, Hyun Jung, Oh, Sung Yong, Park, Keon Woo, Lim, Do Hyeong, Lee, Soon Il, Kim, Jung-Han, Kim, Kyoung Mee, Lee, Dae Ho, Lee, Jeeyun
Published 2010

Repotrectinib (TPX-0005) is a next-generation ROS1/TRK/ALK inhibitor that potently inhibit ROS1/TRK/ALK solvent-front mutations

by Drilon, Alexander, Ou, Sai-Hong Ignatius, Cho, Byoung Chul, Kim, Dong-Wan, Lees, Jeeyun, Lin, Jessica J., Zhu, Viola W., Ahns, Myung-Ju, Camidge, D. Ross, Nguyen, Judy, Zhai, Dayong, Deng, Wei, Huang, Zhongdong, Rogers, Evan, Liu, Juliet, Whitten, Jeff, Lim, John K., Stopatschinskaja, Shanna, Hyman, David M., Doebele, Robert C., Cui, J. Jean, Shaw, Alice T.
Published 2020

Prevalence and detection of low-allele-fraction variants in clinical cancer samples

by Shin, Hyun-Tae, Choi, Yoon-La, Yun, Jae Won, Kim, Nayoung K. D., Kim, Sook-Young, Jeon, Hyo Jeong, Nam, Jae-Yong, Lee, Chung, Ryu, Daeun, Kim, Sang Cheol, Park, Kyunghee, Lee, Eunjin, Bae, Joon Seol, Son, Dae Soon, Joung, Je-Gun, Lee, Jeeyun, Kim, Seung Tae, Ahn, Myung-Ju, Lee, Se-Hoon, Ahn, Jin Seok, Lee, Woo Yong, Oh, Bo Young, Park, Yeon Hee, Lee, Jeong Eon, Lee, Kwang Hyuk, Kim, Hee Cheol, Kim, Kyoung-Mee, Im, Young-Hyuck, Park, Keunchil, Park, Peter J., Park, Woong-Yang
Published 2017

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

by Kelly, Ronan J., Lee, Jeeyun, Bang, Yung-Jue, Almhanna, Khaldoun, Blum-Murphy, Mariela, Catenacci, Daniel V. T., Hyun Cheol Chung, Wainberg, Zev A., Gibson, Michael K., Lee, Keun-Wook, Bendell, Johanna C., Denlinger, Crystal S., Chee, Cheng Ean, Omori, Takeshi, Leidner, Rom, Lenz, Heinz-Josef, Chao, Yee, Rebelatto, Marlon C., Brohawn, Philip Z., He, Peng, McDevitt, Jennifer, Sheth, Siddharth, Englert, Judson M., Ku, Geoffrey Y.
Published 2021

Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

by Lee, Jeeyun, Kim, Tae-You, Lee, Myung Ah, Ahn, Myung Ju, Kim, Hoon-Kyo, Lim, Ho Yeong, Lee, Nam Su, Park, Byung Joo, Kim, Jun Suk
Published 2010

Landscape of actionable genetic alterations profiled from 1,071 tumor samples in Korean cancer patients

by Lee, Se-Hoon, Lee, Boram, Shim, Joon Ho, Lee, Kwang Woo, Yun, Jae Won, Kim, Sook-Young, Kim, Tae-You, Kim, Yeul Hong, Ko, Young Hyeh, Chung, Hyun Cheol, Yu, Chang Sik, Lee, Jeeyun, Rha, Sun Young, Kim, Tae Won, Jung, Kyung Hae, Im, Seock-Ah, Moon, Hyeong-Gon, Cho, Sukki, Kang, Jin Hyoung, Kim, Jihun, KIm, SA, Ryu, Han Suk, Ha, Sang Yun, Kim, Jong Il, Chung, Yeun-Jun, Kim, Cheolmin, Kim, Hyung-Lae, Park, Woong-Yang, Noh, Dong-Young, Park, Keunchil]
Published 2022

Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma

by Catenacci, Daniel V. T., Rasco, Drew, Lee, Jeeyun, Rha, Sun Young, Lee, Keun-Wook, Bang, Yung Jue, Bendell, Johanna, Enzinger, Peter, Marina, Neyssa, Xiang, Hong, Deng, Wei, Powers, Janine, Wainberg, Zev A.
Published 2021

Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

by Lee, Jeeyun, Jung, Kyung Hae, Park, Young Suk, Ahn, Joong Bae, Shin, Sang Jun, Im, Seock-Ah, Oh, Do Youn, Shin, Dong Bok, Kim, Tae Won, Lee, Namsu, Byun, Jae Ho, Hong, Yong Sang, Park, Joon Oh, Park, Se Hoon, Lim, Ho Yeong, Kang, Won Ki
Published 2010

Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial

by Pavlakis, Nick, Sjoquist, Katrin M., Martin, Andrew J., Tsobanis, Eric, Yip, Sonia, Kang, Yoon-Koo, Bang, Yung-Jue, Alcindor, Thierry, O'Callaghan, Christopher J., Burnell, Margot J., Tebbutt, Niall C., Rha, Sun Young, Lee, Jeeyun, Cho, Jae-Yong, Lipton, Lara R., Wong, Mark, Strickland, Andrew, Kim, Jin Won, Zalcberg, John R., Simes, John, Goldstein, David
Published 2021

High-Throughput Genotyping in Metastatic Esophageal Squamous Cell Carcinoma Identifies Phosphoinositide-3-Kinase and BRAF Mutations

by Maeng, Chi Hoon, Lee, Jeeyun, van Hummelen, Paul, Jang, Jiryeon, Kim, Kyoung-Mee, Shim, Young-Mog, Park, Se Hoon, Palescandolo, Emanuele, Park, Ha Young, Kang, So Young, MacConaill, Laura Eleanor
Published 2013

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial

by Kim, Seung Tae, Hong, Yong Sang, Lim, Ho Yeong, Lee, Jeeyun, Kim, Tae Won, Kim, Kyu-Pyo, Kim, Sun Young, Baek, Ji Yeon, Kim, Jee Hyun, Lee, Keun-Wook, Chung, Ik-Joo, Cho, Sang-Hee, Lee, Kyung Hee, Shin, Sang Joon, Kang, Hye Jin, Shin, Dong Bok, Lee, Jae Won, Jo, Sook Jung, Park, Young Suk
Published 2017